Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion type Assertion NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_head.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion wasGeneratedBy ECO_0000203 NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_provenance.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion wasDerivedFrom befree-20140225 NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_provenance.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion SIO_000772 23582323 NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_provenance.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion evidence source_evidence_literature NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_provenance.
- NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_assertion description "[Treatment of MM tumor cells with the BET-bromodomain inhibitor JQ1 led to preferential loss of BRD4 at super-enhancers and consequent transcription elongation defects that preferentially impacted genes with super-enhancers, including MYC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208084.RASo-8tjyvQyRt4HYKARZziNTANdQdYs9SsVwBjmS69gs130_provenance.